Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Hypoxemia

New insights into treatment with oxygen in intensive care medicine

    • Anesthesiology
    • Pneumology
    • RX
    • Studies
  • 2 minute read

The New England Journal of Medicine (NEJM) recently published the large-scale multinational study “Handling Oxygenation Targets in the Intensive Care Unit” (HOT-ICU). Under the direction of Aalborg University Hospital, the survival rate of critically ill patients with acute pulmonary function limitation (hypoxemia) was studied. One group with lower and one with higher target oxygen levels were compared. Contrary to the original assumption, the mortality rate after 90 days was comparable in both groups.

Critically ill patients with lung dysfunction are often treated with oxygen in intensive care units. Oxygen, one of the oldest and most widely used drugs, is often supplied by mechanical ventilation, and a certain oxygen partial pressure (oxygen target value) in the blood is aimed for. However, different strategies with either higher or lower oxygen partial pressure are used in intensive care units worldwide. In intensive care practice and in the scientific literature, the respective benefits or risks of corresponding strategies remained unclear.

Surprising results

The results of the HOT-ICU study show no difference in 90-day mortality when critically ill patients in the higher (n = 1447.90 mmHg arterial partial pressure) and lower (n = 1441.60 mmHg arterial partial pressure) target group are compared. Thus, a lower target oxygen value does not reduce mortality after 90 days. Similarly, no significant difference was found for the criteria “proportion of days without life-sustaining measures” and “proportion of days without hospitalization”. 

Large-scale multinational study

The HOT-ICU pragmatic study was conducted by a scientific team led by Aalborg University Hospital at 35 intensive care centers in Denmark, Finland, the Netherlands, Norway, the United Kingdom, Iceland, and Switzerland (Basel and Bern University Hospitals). It included 2928 adult critically ill patients with an oxygen demand of at least 10 liters per minute or an inspired oxygen percentage of 50%. Allocation to the two treatment groups (90 mmHg or 60 mmHg arterial partial pressure of oxygen) was randomized. The primary endpoint of the study was mortality at 90 days. The number of days without (necessary) life-sustaining measures, the number of days without hospitalization, and the ratio of patients with shock, myocardial infarction, stroke, and gastrointestinal circulatory disorders were also documented. 

Outlook

After intensive discussions on the strategy of target oxygen levels in critically ill patients in recent years and arguments for and against both approaches, the current study results seem to support a “conservative” oxygen administration with lower target oxygen levels in adult critically ill patients. Prof. Joerg C. Schefold, MD, Chief of the Department of Intensive Care Medicine at Inselspital, University Hospital Bern, and member of the scientific team explains: “The study results on this everyday intensive care question are important because they contribute to a better understanding of the effects of corresponding strategies. They show that the ‘conservative’ strategy is not associated with a lower mortality rate. We expect our data to influence international recommendations regarding target oxygen levels to aim for in adult critically ill patients requiring oxygen supplementation.”

Source: University Hospital Bern

Original publication:

DOI: 10.1056/NEJMoa2032510, Publication in NEJM “Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure.”

Previous Article
  • REMAP-CAP Study Group

COVID-19: New treatment recommendations in intensive care units.

  • Anesthesiology
  • Infectiology
  • News
  • RX
  • Studies
View Post
Next Article
  • Venous thromboembolism

Risks associated with hormone therapy

  • Cardiology
  • CME continuing education
  • Education
  • Endocrinology and Diabetology
  • General Internal Medicine
  • Gynecology
  • Neurology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 3 min
  • Adherence and management in asthma and COPD

Better to listen to the pharmacist

    • RX
    • Education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Pneumology
    • Studies
View Post
  • 14 min
  • Focus Update 2026

Echocardiography in Cardio-Oncology

    • RX
    • Cardiology
    • Education
    • Oncology
    • Radiology
    • Studies
View Post
  • 4 min
  • Physical activity with IBD

Sport is not murder, but it doesn’t help either

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Sports Medicine
    • Studies
View Post
  • 3 min
  • White and Black Skin Cancer

Biology and Modern Therapeutic Approaches

    • RX
    • Dermatology and venereology
    • Education
    • Oncology
    • Prevention and health care
    • Studies
    • Surgery
View Post
  • 5 min
  • Highlights from the AAD Annual Meeting

Atopic Dermatitis: Interesting News on Drug Candidates in Phase III

    • RX
    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Studies
View Post
  • 6 min
  • Autoimmune Liver Diseases

Innovative Treatment Approaches for PBC, PSC, and AIH: What’s New?

    • RX
    • Congress Reports
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Studies
View Post
  • 8 min
  • Myelofibrosis

Mutations and Molecular Diagnostics in Treatment Decisions

    • RX
    • Education
    • Hematology
    • Oncology
    • Studies
View Post
  • 5 min
  • Psoriasis in the Age of Precision Medicine

Systemic Therapy for Patients with Comorbidities: What Is the Best Choice?

    • RX
    • Cardiology
    • Congress Reports
    • Dermatology and venereology
    • Gastroenterology and Hepatology
    • Nutrition
    • Rheumatology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.